SaxoCell
SaxoCell is a regional, BMBF-funded future cluster with the aim of making effective, safe and affordable autologous and allogeneic cell and gene therapies (ZGT), so-called "living drugs", available to patients. The cluster involves close cooperation between scientists from TU Dresden, Leipzig University and Fraunhofer IZI, medical doctors from the university hospitals in Dresden and Leipzig and the Chemnitz Hospital, as well as researchers and application specialists from industry (from SMEs to production specialists and pharmaceuticals). The research topics include more effective CAR-T, CAR-NK and macrophage therapies for oncology and autoimmune diseases, as well as novel, non-viral gene editing methods and MSC therapies for the treatment of lung diseases in premature babies.
With SaxoCellutions, the TUD|excite supports the future cluster SaxoCell in achieving its goals. The team supports the R&D projects in all matters relating to transfer, IP, start-ups and project management and also offers transfer-specific further training opportunities for researchers. It also handles internal and external communication with stakeholders.
The team:
© Magdalena Gonciarz
Luisa Brückner
Innovations- und Startup-Management SaxoCell
Send encrypted email via the SecureMail portal (for TUD external users only).
© Sven Ellger
Cathleen Meerheim
Innovationsmanagement SaxoCell
Send encrypted email via the SecureMail portal (for TUD external users only).
© Magdalena Gonciarz
Stephanie Wieneke
Innovations- und Startup-Management SaxoCell
Send encrypted email via the SecureMail portal (for TUD external users only).